A
Aura Biosciences
AURA
9.85000
USD
-0.32
(-3.15%)
مغلق
حجم التداول
7,115
الربح لكل سهم
0
العائد الربحي
0
P/E
-6
حجم السوق
503,006,006
العنوان: Aura Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.